• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞骨架靶向钌多吡啶配合物的药效团研究。

Exploration of the Pharmacophore for Cytoskeletal Targeting Ruthenium Polypyridyl Complexes.

机构信息

Department of Chemistry and Biochemistry, University of Texas at Arlington, 700 Planetarium Place, Arlington, TX, 76109, USA.

出版信息

ChemMedChem. 2023 Nov 2;18(21):e202300347. doi: 10.1002/cmdc.202300347. Epub 2023 Aug 29.

DOI:10.1002/cmdc.202300347
PMID:37574460
Abstract

Ruthenium(II) trisdiimine complexes of the formula, [Ru(dip) (L-L) ] , where n=0-3; dip=4,7-diphenyl-1,10-phenanthroline; L-L=2,2'-bipyridine (bpy) or 1,10-phenanthroline (phen) were prepared and tested for cytotoxicity in two cell lines (H358, MCF7). Cellular uptake and subcellular localization were determined by harvesting treated cells and determining the ruthenium concentration in whole or fractionated cells (cytosolic, nuclear, mitochondrial/ ER/Golgi, and cytoskeletal proteins) by Ru ICP-MS. The logP values for the chloride salts of these complexes were measured and the data were analyzed to determine the role of lipophilicity versus structure in the various biological assays. Cellular uptake increased with lipophilicity but shows the biggest jump when the complex contains two or more dip ligands. Significantly, preferential cytoskeletal localization is also correlated with increased cytotoxicity. All of the RPCs promote tubulin polymerization in vitro, but [Ru(dip) phen] and [Ru(dip) ] show the strongest activity. Analysis of the pellet formed by centrifugation of MTs formed in the presence of [Ru(dip) phen] establish a binding stoichiometry of one RPC per tubulin heterodimer. Complexes of the general formula [Ru(dip) (L-L)] possess the necessary characteristics to target the cytoskeleton in live cells and increase cytotoxicity, however the nature of the L-L ligand does influence the extent of the effect.

摘要

钌(II)三二亚胺配合物的公式为,[Ru(dip)(L-L)],其中 n=0-3;dip=4,7-二苯基-1,10-菲咯啉;L-L=2,2'-联吡啶(bpy)或 1,10-菲咯啉(phen),被制备并在两种细胞系(H358、MCF7)中进行了细胞毒性测试。通过收集处理过的细胞并通过 Ru ICP-MS 测定整个或分馏细胞(细胞质、核、线粒体/内质网/高尔基体和细胞骨架蛋白)中的钌浓度来确定细胞摄取和亚细胞定位。这些配合物的氯化物盐的 logP 值进行了测量,并对数据进行了分析,以确定亲脂性与结构在各种生物测定中的作用。细胞摄取随着亲脂性的增加而增加,但当配合物含有两个或更多的 dip 配体时,增加幅度最大。值得注意的是,优先细胞骨架定位也与增加的细胞毒性相关。所有 RPC 都能促进微管蛋白在体外聚合,但[Ru(dip)phen]和[Ru(dip)]表现出最强的活性。对在[Ru(dip)phen]存在下形成的 MTs 进行离心形成的沉淀的分析确定了每个 RPC 与每个微管蛋白异二聚体的结合计量比。具有通式[Ru(dip)(L-L)]的配合物具有靶向活细胞中细胞骨架并增加细胞毒性的必要特征,但是 L-L 配体的性质确实会影响影响的程度。

相似文献

1
Exploration of the Pharmacophore for Cytoskeletal Targeting Ruthenium Polypyridyl Complexes.细胞骨架靶向钌多吡啶配合物的药效团研究。
ChemMedChem. 2023 Nov 2;18(21):e202300347. doi: 10.1002/cmdc.202300347. Epub 2023 Aug 29.
2
Synthesis, DNA Cleavage Activity, Cytotoxicity, Acetylcholinesterase Inhibition, and Acute Murine Toxicity of Redox-Active Ruthenium(II) Polypyridyl Complexes.氧化还原活性钌(II)多吡啶配合物的合成、DNA切割活性、细胞毒性、乙酰胆碱酯酶抑制作用及小鼠急性毒性
ChemMedChem. 2017 Jul 6;12(13):1055-1069. doi: 10.1002/cmdc.201700240. Epub 2017 Jun 12.
3
Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.四种钌多吡啶配合物作为抗肿瘤药物的研发:设计、生物学评价及作用机制研究
J Inorg Biochem. 2020 Jul;208:111104. doi: 10.1016/j.jinorgbio.2020.111104. Epub 2020 May 19.
4
Synthesis, Characterization, Cytotoxic Activity, and Metabolic Studies of Ruthenium(II) Polypyridyl Complexes Containing Flavonoid Ligands.合成、表征、含有黄酮配体的钌(II) 多吡啶配合物的细胞毒性活性和代谢研究。
Inorg Chem. 2020 Apr 6;59(7):4424-4434. doi: 10.1021/acs.inorgchem.9b03562. Epub 2020 Mar 19.
5
Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.以多吡啶为辅助配体的钌(II)白花丹醌配合物通过抑制能量代谢和GADD45A介导的细胞周期阻滞发挥抗癌活性。
Eur J Med Chem. 2022 Jun 5;236:114312. doi: 10.1016/j.ejmech.2022.114312. Epub 2022 Mar 30.
6
New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.新型含氟原子或呋喃基的钌多吡啶配合物的合成、DNA 结合、细胞毒性及抗肿瘤机制研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Feb 15;227:117534. doi: 10.1016/j.saa.2019.117534. Epub 2019 Oct 25.
7
Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.系统评价三种钌多吡啶配合物的抗肿瘤活性。
J Inorg Biochem. 2021 Dec;225:111616. doi: 10.1016/j.jinorgbio.2021.111616. Epub 2021 Sep 20.
8
Synthesis, characterization and antitumor mechanism investigation of ruthenium(II) polypyridyl complexes with artesunate moiety.含青蒿琥酯部分的钌(II)多吡啶配合物的合成、表征及抗肿瘤机制研究
J Biol Inorg Chem. 2021 Dec;26(8):909-918. doi: 10.1007/s00775-021-01901-8. Epub 2021 Sep 20.
9
Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.新型含异喹啉配体的环金属化 Ru(II) 配合物的合成、表征、细胞摄取和体外细胞毒性。
Eur J Med Chem. 2020 Oct 1;203:112562. doi: 10.1016/j.ejmech.2020.112562. Epub 2020 Jul 15.
10
Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.含2(2,6-二甲氧基吡啶-3-基)-1H-咪唑并(4,5-f)[1,10]菲咯啉的钌(II)化合物的合成、结构表征、体外DNA结合及抗肿瘤活性性质
Nucleosides Nucleotides Nucleic Acids. 2020;39(5):760-791. doi: 10.1080/15257770.2019.1694685. Epub 2020 Jan 25.

引用本文的文献

1
Minimal Functionalization of Ruthenium Compounds with Enhanced Photoreactivity against Hard-to-Treat Cancer Cells and Resistant Bacteria.最小功能化钌化合物提高了对难治疗癌细胞和耐药菌的光反应性。
Inorg Chem. 2024 Aug 5;63(31):14673-14690. doi: 10.1021/acs.inorgchem.4c02235. Epub 2024 Jul 23.